Kathleen D. Scott, Director at Dermata Therapeutics, Inc. (DRMA), sold 11 shares at $1.19 ($13) on 2026-06-16, disclosed to the SEC on 2026-06-16.
Open-market sale of $13 DRMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SPRY | SELL | 2024-10-17 | $200K | — | Filing → |
| SPRY | SELL | 2024-08-21 | $200K | — | Filing → |
| SPRY | BUY | 2022-12-01 | $51K | — | Filing → |